ECT remains the most effective known treatment for depression of any kind, and most if not all practice guidelines advise that it deserves serious consideration in depressions that do not respond to multiple medication trials. Medicines that aren't very effective in resolving a depression are sometimes nevertheless effective in preventing a relapse after ECT, otherwise, continuation or maintenance ECT is sometimes recommended to reduce relapse risk, since the benefits of ECT, if a response occurs, typically are transient and some strategy needs to be in place to prevent relapse (whether that strategy is a medication approach or just maintenance ECT).
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
The opinions expressed in WebMD Communities are solely those of the User, who may or may not have medical or scientific training. These opinions do not represent the opinions of WebMD. Communities are not reviewed by a WebMD physician or any member of the WebMD editorial staff for accuracy, balance, objectivity, or any other reason except for compliance with our Terms and Conditions. Some of these opinions may contain information about treatments or uses of drug products that have not been approved by the U.S. Food and Drug Administration. WebMD does not endorse any specific product, service or treatment.
Do not consider Communities as medical advice. Never delay or disregard seeking professional medical advice from your doctor or other qualified healthcare provider because of something you have read on WebMD. You should always speak with your doctor before you start, stop, or change any prescribed part of your care plan or treatment. WebMD understands that reading individual, real-life experiences can be a helpful resource, but it is never a substitute for professional medical advice, diagnosis, or treatment from a qualified health care provider. If you think you may have a medical emergency, call your doctor or dial 911 immediately.